Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP986698.RAdfD2YcasB1E9-Svybc5F81o4gNG8896R1Y7lCa6kUxA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP986698.RAdfD2YcasB1E9-Svybc5F81o4gNG8896R1Y7lCa6kUxA130_assertion type Assertion NP986698.RAdfD2YcasB1E9-Svybc5F81o4gNG8896R1Y7lCa6kUxA130_head.
- NP986698.RAdfD2YcasB1E9-Svybc5F81o4gNG8896R1Y7lCa6kUxA130_assertion description "[Somatic inactivation of the VHL gene is the main molecular event in most sporadic RCC and the treatment of advanced RCC has been revolutionized by targeted therapy with drugs that block angiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986698.RAdfD2YcasB1E9-Svybc5F81o4gNG8896R1Y7lCa6kUxA130_provenance.
- NP986698.RAdfD2YcasB1E9-Svybc5F81o4gNG8896R1Y7lCa6kUxA130_assertion evidence source_evidence_literature NP986698.RAdfD2YcasB1E9-Svybc5F81o4gNG8896R1Y7lCa6kUxA130_provenance.
- NP986698.RAdfD2YcasB1E9-Svybc5F81o4gNG8896R1Y7lCa6kUxA130_assertion SIO_000772 22659535 NP986698.RAdfD2YcasB1E9-Svybc5F81o4gNG8896R1Y7lCa6kUxA130_provenance.
- NP986698.RAdfD2YcasB1E9-Svybc5F81o4gNG8896R1Y7lCa6kUxA130_assertion wasDerivedFrom befree-2016 NP986698.RAdfD2YcasB1E9-Svybc5F81o4gNG8896R1Y7lCa6kUxA130_provenance.
- NP986698.RAdfD2YcasB1E9-Svybc5F81o4gNG8896R1Y7lCa6kUxA130_assertion wasGeneratedBy ECO_0000203 NP986698.RAdfD2YcasB1E9-Svybc5F81o4gNG8896R1Y7lCa6kUxA130_provenance.